Foundation of the additional manufacturing plant in Cerkezkoy with the area of 23.300 square meters is laid
700 Million TL of Investment from World Medicine
World Medicine, which has operated in Turkey since 2011, is continuing its investments without pausing. World Medicine, which laid the foundation of the construction in the area of 17.582 square meters for the new additional manufacturing plant and packaging area in Cerkezkoy, is working to become the pharmaceutical company, which makes the most contribution to the Turkish economy.
World Medicine, which has taken important steps under the target of exporting the drugs, which are manufactured in Turkey, to the world with the investment for the new additional manufacturing plant and packaging area in Cerkezkoy, is continuing to grow in Turkey and international arena in the pharmaceutical industry day by day with the investments made.
700 Million TL of Investment
Sohrab Mammadov, Vice Board Chairman of World Medicine, who has stated that they launched one of the largest pharmaceutical manufacturing plants of Turkey in Cerkezkoy Organized Industrial Site last year, said “There are our laboratories, which have high technology devices and ensure that we can make several analyses easily, in our manufacturing plant, which has one of the largest production areas of Turkey and has high technology machines. When our investment for the additional manufacturing plant, which we laid the foundation in the previous days with the investment of about 700 million TL, and which will be built on the area of 17.582 square meters, is completed, it will have a total closed area of 23.300 square meters.”
We are increasing our pharmaceutical production day by day
Sohrab Mammadov, who stated that they would also continue the investments in 2023 to create added value both for the sector and the economy in Turkey, spoke “We are continuing our enterprises to increase the products, which we offered to the market in Turkey, as well as the number of countries, to which we export. It is very important for us to become a reliable business partner and a leading company in all the countries and fields, in which we operate. We are consolidating our infrastructure for more pharmaceutical export; we are increasing our pharmaceutical manufacturing capacity day by day with our manufacturing plants, which are equipped with high technology.”
